Intercept Pharmaceuticals, Inc...

NASDAQ: ICPT
$72.26
-$0.48 (-0.7%)
Closing price May 29, 2020
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
Chris Lange
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
Chris Lange
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
Chris Lange
We screened our 24/7 Wall St. research database for hot biotech ideas and found four companies that are offering big upside for aggressive accounts. All are rated Buy and have the potential to...
Lee Jackson
There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be one.
Lee Jackson
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Chris Lange
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
Chris Lange
These four momentum biotech plays still have solid upside to the Jefferies price targets and would be solid additions to aggressive accounts with higher risk tolerance.
Lee Jackson
Windstream, Uniti Group, Intercept Pharmaceuticals, and Genocea Biosciences all posted new 52-week lows on Wednesday.
Paul Ausick
Versartis, Intercept Pharma, Kroger, and Mattel all posted new 52-week lows on Friday.
Paul Ausick
Kroger, Bed Bath & Beyond, Intercept Pharmaceuticals, and Mattel all posted new 52-week lows on Thursday.
Paul Ausick
As we have said before, updates from the FDA have the potential to make or break a company. In this case it seems like a mild setback, but further complications could prove to be catastrophic.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson, 3M, Intercept Pharmaceutical and AutoZone.
Jon C. Ogg
HP Enterprise, Discovery Communications, Intercept Technologies, and Advaxis all posted new 52-week lows on Tuesday.
Paul Ausick
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
Chris Lange